Author

Jennifer Sacolick

Institution: Agios Pharmaceuticals (United States)

Observed institution: Agios Pharmaceuticals (United States)

OpenAlex ID: A5048037718

Determination of IDH1 Mutational Burden and Clearance Via Next-Generation Sequencing in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Inhibitor of Mutant IDH1

2016 · Courtney D DiNardo, Stéphane de Botton, et al. · Blood · 35

Works count: 1

Citation count: 35

H-index: 1

I10-index: 1